1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Abercrombie & Fitch reported third-quarter fiscal 2025 results on November 25, 2025, with net sales up 7% to $1.3 billion, while diluted earnings per share fell to $2.36 from $2.50 and operating margin declined to 12.0% from 14.8%. The company narrowed its full-year net income per diluted share outlook to $10.20 to $10.50 from $10.00 to $10.50, raising the low end of the range, and repurchased $100 million of shares in the quarter.
Q3 net sales of $1.3 billion, up 7% from a year earlier; comparable sales rose 3%.
Operating income of $155 million vs. $179 million a year earlier; diluted EPS of $2.36 vs. $2.50.
Full-year fiscal 2025 diluted EPS outlook narrowed to $10.20 to $10.50 from $10.00 to $10.50; Q4 EPS outlook is $3.40 to $3.70.
$100 million of shares repurchased in Q3; $950 million remains on the March 2025 authorization.
HP reported fiscal 2025 results on November 25, 2025, with net revenue of $55.3 billion, up 3.2%, while GAAP diluted EPS fell 5.7% to $2.65 and non-GAAP diluted EPS fell 9.0% to $3.12. The same day, the Board approved an AI-focused plan with approximately $650 million in restructuring and other charges and estimated gross run rate savings of approximately $1 billion by the end of fiscal 2028. The company also raised its quarterly dividend to $0.30 per share, and its fiscal 2026 non-GAAP diluted EPS outlook is $2.90 to $3.20.
FY25 net revenue was $55.3 billion, up 3.2%; GAAP diluted EPS was $2.65, down from $2.81 a year earlier.
The plan includes approximately $650 million in restructuring and other charges, of which approximately $550 million is cash, with approximately $250 million in fiscal 2026.
Workforce reductions of approximately 4,000 to 6,000 employees are expected by the end of fiscal 2028, with about $400 million of the charges in labor costs.
Quarterly dividend increases to $0.30 per share, payable January 2, 2026 to holders of record as of December 11, 2025.
J.M. Smucker reported fiscal 2026 second-quarter net sales of $2.3 billion, up 3%, driven by higher net pricing, while adjusted earnings per share fell 24% to $2.10. The company narrowed its full-year adjusted EPS guidance to $8.75 to $9.25 from $8.50 to $9.50, which keeps the midpoint at $9.00 unchanged.
Net sales were $2,330.1 million, up 3% from $2,271.2 million; excluding divestitures and currency, sales rose 5%.
Adjusted EPS was $2.10 versus $2.76 a year earlier; GAAP diluted EPS was $2.26 versus a loss of $0.23.
Fiscal 2026 adjusted EPS guidance is $8.75 to $9.25, down from the prior $8.50 to $9.50 range at the top end and up at the bottom; net sales growth guidance is 3.5% to 4.5%.
Free cash flow was $280.2 million versus $317.2 million a year earlier; full-year free cash flow guidance is unchanged at $975.0 million.
DICK'S Sporting Goods reported third-quarter results that showed higher sales but a sharp drop in GAAP earnings per share, which fell to $0.86 from $2.75 a year earlier, largely reflecting the September 8, 2025 Foot Locker acquisition. The company raised its full-year 2025 comparable sales and EPS outlook for the DICK'S Business, while expecting future pre-tax charges of $500 million to $750 million tied to reviewing unproductive Foot Locker assets and merger costs.
Q3 GAAP EPS was $0.86 versus $2.75 a year earlier; non-GAAP EPS for the DICK'S Business was $2.78 versus $2.75
Full-year 2025 DICK'S Business EPS guidance raised to $14.25 to $14.55 from $13.90 to $14.50; comparable sales guidance raised to 3.5% to 4.0% from 2.0% to 3.5%
Foot Locker acquired September 8, 2025 for $2.5 billion; Q4 Foot Locker gross margin expected to be down 1,000 to 1,500 basis points
Quarterly dividend of $1.2125 per share declared, payable December 26, 2025 to holders of record on December 12, 2025
Best Buy reported third-quarter fiscal 2026 results with enterprise revenue of $9.67 billion and comparable sales up 2.7%, after a 2.9% decline a year earlier. GAAP diluted EPS fell to $0.66 from $1.26 because of a $171 million goodwill and intangible impairment tied to Best Buy Health, while adjusted diluted EPS rose to $1.40 from $1.26. The company raised its FY26 adjusted diluted EPS guidance to $6.25 to $6.35 from $6.15 to $6.30.
Enterprise revenue of $9,672 million in Q3 FY26 vs. $9,445 million a year earlier; comparable sales up 2.7%
GAAP diluted EPS of $0.66 vs. $1.26 last year, reflecting $192 million of Best Buy Health impairments in the quarter
Adjusted diluted EPS of $1.40 vs. $1.26 last year
FY26 guidance raised: adjusted diluted EPS to $6.25 to $6.35 (from $6.15 to $6.30) and revenue to $41.65 billion to $41.95 billion (from $41.1 billion to $41.9 billion)
Kohl's reported third-quarter fiscal 2025 results, with net sales down 2.8% to $3.4 billion and diluted EPS of $0.07 versus $0.20 a year earlier. The company raised its full-year 2025 outlook, though it still expects net sales to fall 3.5% to 4%, and named Michael Bender permanent CEO. Shareholders face a mixed picture: weaker sales and profit in the quarter alongside a higher full-year outlook.
Q3 net sales fell 2.8% to $3.4 billion; comparable sales fell 1.7%
Q3 diluted EPS was $0.07 versus $0.20 a year earlier; adjusted diluted EPS was $0.10 versus $0.20
Full-year 2025 adjusted diluted EPS guidance is $1.25 to $1.45; net sales guidance is a decrease of 3.5% to 4%
Nine-month net income of $147 million included a $129 million gain on a credit card interchange fee lawsuit settlement
Matthews International reported fourth-quarter fiscal 2025 sales of $318.8 million, down 28.6% from a year earlier, and a GAAP net loss of $27.5 million, or $0.88 per diluted share, compared with a loss of $68.2 million a year earlier. The company said the SGK divestiture was a significant factor in the year-over-year comparison. It also targets fiscal 2026 adjusted EBITDA of at least $180 million, below the $187.5 million reported for fiscal 2025.
Q4 sales of $318.8 million vs. $446.7 million a year earlier; fiscal 2025 sales of $1.50 billion vs. $1.80 billion
Q4 non-GAAP EPS of $0.50 vs. $0.55 a year earlier; fiscal 2025 non-GAAP EPS of $1.26 vs. $2.17
Fiscal 2026 adjusted EBITDA target of at least $180 million, including the 40% share of Propelis, vs. $187.5 million in fiscal 2025
Pending warehouse automation sale is expected to reduce the net leverage ratio below 3.0x, with proceeds mainly for debt reduction
BJ's Wholesale Club Holdings reported third-quarter fiscal 2025 results for the thirteen weeks ended November 1, 2025. Total revenues rose 4.9% to $5.35 billion, but net income fell 2.4% to $152.1 million and diluted EPS slipped to $1.15 from $1.17. The company raised its adjusted EPS outlook for fiscal 2025 to $4.30 to $4.40.
Total revenues rose 4.9% to $5.35 billion; net sales rose 4.8% to $5.22 billion
Net income fell 2.4% to $152.1 million; diluted EPS was $1.15 versus $1.17; adjusted EPS was $1.16 versus $1.18
Fiscal 2025 adjusted EPS outlook raised to $4.30 to $4.40; comparable club sales excluding gasoline guided to rise 2.0% to 3.0%
Membership fee income rose 9.8% to $126.3 million; the company repurchased $87.3 million of stock in the quarter
Gap Inc. reported third quarter fiscal 2025 net sales of $3.9 billion, up 3% from a year earlier, with comparable sales up 5%. Diluted earnings per share fell to $0.62 from $0.72, and the company raised its full-year operating margin outlook and its net sales growth outlook, which shareholders should weigh against the lower quarterly profit.
Q3 net sales $3.9 billion, up 3%; comparable sales up 5%, the seventh straight quarter of positive comparable sales
Q3 net income $236 million vs. $274 million a year earlier; diluted EPS $0.62 vs. $0.72
Fiscal 2025 operating margin outlook raised to approximately 7.2% from 6.7% to 7.0%; net sales growth outlook raised to 1.7% to 2.0%
Board approved a fourth quarter fiscal 2025 dividend of $0.165 per share
Universal Technical Institute reported fiscal 2025 revenue of $835.6 million, up 14.0%, and net income of $63.0 million, up 50.0%, with diluted EPS of $1.13 versus $0.75. For fiscal 2026 it guided to net income of $40 million to $45 million and diluted EPS of $0.71 to $0.80, both down 33% at the midpoint, and it said planned growth investments will temporarily moderate margins.
FY2025 revenue $835.6 million, up 14.0%; net income $63.0 million, up 50.0%; diluted EPS $1.13 versus $0.75
Q4 FY2025 revenue $222.4 million, up 13.3%; Q4 net income $18.8 million, flat versus $18.8 million; Q4 adjusted EBITDA $36.8 million, down 1.4%
FY2026 guidance: revenue $905 million to $915 million; net income $40 million to $45 million; adjusted EBITDA $114 million to $119 million versus $126.5 million in FY2025
Company expects to open at least two and up to five campuses and launch about 20 new programs annually, pending regulatory approval
Lowe's reported third-quarter 2025 sales of $20.8 billion, up from $20.2 billion a year earlier, but diluted EPS fell to $2.88 from $2.99. Adjusted diluted EPS rose 5.9% to $3.06 after excluding $129 million in acquisition-related expenses. The company raised its full-year sales outlook to $86.0 billion but lowered its comparable sales and adjusted operating margin outlook, so the update is mixed for shareholders.
Net earnings were $1.6 billion ($1,616 million) versus $1.7 billion ($1,695 million) in the prior-year quarter.
Comparable sales rose 0.4%, with online sales up 11.4%.
Full-year comparable sales are now expected to be flat, previously flat to up 1%; adjusted operating margin is now 12.1%, previously 12.2% to 12.3%.
Full-year adjusted diluted EPS is now approximately $12.25, previously $12.20 to $12.45.
Griffon reported fiscal 2025 revenue of $2.5 billion, down 4% from the prior year, and net income of $51.1 million ($1.09 per share), down from $209.9 million ($4.23 per share). Results included a $217.2 million net-of-tax charge for third-quarter goodwill and intangible asset impairments in the Consumer and Professional Products segment, while adjusted net income rose to $263.6 million ($5.65 per share). The company also announced a 22% increase in its regular quarterly dividend to $0.22 per share.
Fiscal 2025 revenue was $2.5 billion, down 4% from $2.6 billion; fourth-quarter revenue was $662.2 million, up from $659.7 million.
Fourth-quarter net income was $43.6 million ($0.95 per share), down from $62.5 million ($1.29 per share); adjusted net income was $70.9 million ($1.54 per share) versus $70.9 million ($1.47 per share).
Free cash flow was $323.0 million in fiscal 2025, and leverage fell to 2.4x from 2.6x; the company repurchased 1.9 million shares for $134.7 million.
For fiscal 2026, Griffon expects revenue of $2.5 billion and adjusted EBITDA of $580 million to $600 million.
Valvoline reported fourth-quarter and fiscal 2025 results, with Q4 net revenues up 4% to $453.8 million but reported diluted EPS down 71% to $0.20. The company said it expects to close the $593 million Breeze Autocare acquisition on December 1, 2025, funded by a new $740 million Term Loan B, and gave fiscal 2026 adjusted EPS guidance of $1.60 to $1.70.
Q4 net revenues $453.8 million, up 4%; system-wide same-store sales up 6.0%
Q4 income from continuing operations $25.6 million, down 71%; adjusted EPS $0.45, down 2%
Fiscal 2026 outlook includes Breeze: net revenues $2.0 to $2.1 billion, adjusted EBITDA $525 to $550 million, adjusted EPS $1.60 to $1.70
Breeze deal: $593 million net purchase price, closing planned December 1, 2025; Investor Update scheduled December 11, 2025
La-Z-Boy reported fiscal second-quarter sales of $522 million, up slightly from a year earlier, while GAAP operating income fell 7% and GAAP diluted EPS was $0.70 versus $0.71. The company also completed a 15-store acquisition, plans to exit non-core businesses, proposed closing its U.K. manufacturing facility, and guided third-quarter sales of $525-545 million.
Sales of $522 million for the quarter ended October 25, 2025, up 0.3%; GAAP operating income of $36.2 million, down 7%.
GAAP diluted EPS of $0.70 versus $0.71 a year earlier; adjusted diluted EPS flat at $0.71.
Third-quarter outlook: sales of $525-545 million and adjusted operating margin of 5.0-6.5%.
Quarterly dividend raised 10% to $0.242 per share, payable December 15, 2025, to holders of record on December 4, 2025.
AECOM reported fiscal fourth-quarter 2025 results with revenue up 2% to $4.2 billion, but GAAP net income fell 22% to $132 million and diluted EPS fell 21% to $0.99. For the full year, net income rose 26% to $638 million and diluted EPS rose 29% to $4.79, and the company initiated fiscal 2026 adjusted EPS guidance of $5.65 to $5.85 along with a review of strategic alternatives for its Construction Management business, including a possible sale. The Board also raised the quarterly dividend 19% to $0.31 per share.
Fiscal Q4 2025: revenue $4.2 billion (up 2%), operating income $237 million (flat), net income $132 million (down 22%), diluted EPS $0.99 (down 21%).
Full year fiscal 2025: revenue $16.1 billion (flat), operating income $1.0 billion (up 24%), net income $638 million (up 26%), diluted EPS $4.79 (up 29%).
Fiscal 2026 adjusted EPS guidance of $5.65 to $5.85 for the enterprise-wide business, or $5.15 to $5.35 excluding Construction Management.
Quarterly dividend raised to $0.31 per share from $0.26, payable January 23, 2026 to holders of record as of January 7, 2026.
Home Depot reported third-quarter fiscal 2025 sales of $41.4 billion, up 2.8%, including about $900 million from the GMS acquisition, but diluted earnings per share fell 1.4% to $3.62 and adjusted EPS fell to $3.74 from $3.78. The company said results missed its expectations, citing few storms and weak housing and consumer demand, and it updated its fiscal 2025 guidance to project diluted EPS down about 6.0% from $14.91, which lowers the earnings outlook for shareholders.
Q3 fiscal 2025 net sales $41.4 billion, up $1.1 billion or 2.8%; comparable sales up 0.2%
Q3 diluted EPS $3.62 vs. $3.67 a year earlier; adjusted diluted EPS $3.74 vs. $3.78
Fiscal 2025 guidance: total sales growth about 3.0%, diluted EPS to decline about 6.0% from $14.91, adjusted diluted EPS to decline about 5.0% from $15.24
Spire reported fiscal 2025 net income of $271.7 million ($4.37 per diluted share), up from $250.9 million a year earlier, and adjusted EPS of $4.44, up 7.5% from $4.13. Operating revenues fell to $2.48 billion from $2.59 billion, and the company issued adjusted EPS guidance of $5.25 to $5.45 for fiscal 2026 and $5.65 to $5.85 for fiscal 2027. The board also raised the quarterly common dividend 5.1% to $0.825 per share.
Fiscal 2025 adjusted earnings were $275.5 million ($4.44 per share) versus $247.4 million ($4.13 per share) in fiscal 2024
Operating revenues were $2,476.4 million versus $2,593.0 million; fourth-quarter net loss was $39.8 million ($0.74 per share) versus $25.9 million ($0.51 per share)
Fiscal 2026 adjusted EPS guidance of $5.25 to $5.45 excludes the pending Piedmont Natural Gas Tennessee acquisition; fiscal 2027 guidance of $5.65 to $5.85 includes it
Quarterly common dividend raised to $0.825 per share, payable January 5, 2026, to holders of record December 11, 2025
Edgewell Personal Care reported fourth-quarter and fiscal 2025 results on November 13, 2025, with a fourth-quarter GAAP net loss of $30.6 million after a $51.1 million goodwill impairment tied to its Feminine Care business. Fiscal 2025 GAAP EPS was $0.53, down from $1.97, and the company gave fiscal 2026 guidance that excludes the planned $340 million sale of Feminine Care to Essity.
Q4 net sales were $537.2 million, up 3.8%, but the company posted a GAAP net loss of $30.6 million, or $0.66 per diluted share, versus net income of $8.8 million a year earlier.
Q4 included a non-cash goodwill impairment charge of $51.1 million for the Feminine Care reporting unit.
Fiscal 2025 net sales were $2,223.5 million, down 1.3%, and GAAP diluted EPS was $0.53 versus $1.97 in fiscal 2024.
Fiscal 2026 adjusted EPS is expected at $2.15 to $2.55, compared with fiscal 2025 adjusted EPS of $2.52; the outlook excludes the $340 million Feminine Care divestiture to Essity.
TransDigm reported fourth-quarter fiscal 2025 results for the period ended September 30, 2025, with net sales up 12% to $2,437 million and net income up 30% to $609 million. The company also issued fiscal 2026 guidance calling for net income of $1,906 million to $2,026 million, below fiscal 2025's $2,074 million, which it attributed mainly to added interest expense from fourth-quarter financing.
Q4 net sales $2,437 million, up 12%; net income $609 million, up 30%; EPS $7.75, up 34%
Q4 GAAP EPS reduced by $2.75 from dividend equivalent payments tied to the $90.00 per share special dividend paid September 12, 2025
FY2026 guidance: net sales $9,750 million to $9,950 million; net income $1,906 million to $2,026 million
FY2026 adjusted EPS guidance of $36.49 to $38.53 versus $37.33 in fiscal 2025
Greif reported a two-month fourth quarter ended September 30, 2025, with a net loss from continuing operations of $43.3 million, compared with net income of $34.0 million a year earlier, while Adjusted EBITDA rose 7.4% to $98.9 million. The company also gave low-end fiscal 2026 guidance of $630 million Adjusted EBITDA and $315 million Adjusted free cash flow, raised its cost optimization commitment to $120 million, and plans a share repurchase of about $150 million.
Q4 net loss from continuing operations of $43.3 million, or $(0.73) per diluted Class A share, versus $34.0 million, or $0.58, a year earlier
Adjusted net income fell 98.2% to $0.6 million, or $0.01 per diluted Class A share
Eleven-month fiscal 2025 net income fell 93.2% to $15.1 million, or $0.28 per diluted Class A share; Adjusted EBITDA rose 3.1% to $511.3 million
Containerboard business sold to Packaging Corporation of America for $1.8 billion; timberlands sale for about $462.0 million completed October 1, 2025
Paramount Skydance reported third-quarter 2025 results, with pro forma revenue flat at $6.7 billion versus Q3 2024. The company reported net losses of $244 million before the August 6 deal close and $13 million after it, and issued a 2026 outlook of $30 billion in total revenue and $3.5 billion in adjusted OIBDA. For shareholders, the filing shows flat sales and losses in the reported periods, alongside higher adjusted OIBDA and a raised cost-savings target.
Pro forma Q3 2025 total revenue was $6.7 billion, flat versus $6.7 billion in Q3 2024.
Adjusted OIBDA was $297 million pre-close and $655 million post-close; the company expects Q4 2025 revenue of $8.1 billion to $8.3 billion and 2026 revenue of $30 billion.
Run-rate efficiency target raised to at least $3 billion from $2 billion, and about 1,000 employees were cut at the end of October.
Organon reported third-quarter 2025 revenue of $1.602 billion, up 1% as reported and down 1% excluding foreign exchange, while GAAP net income fell to $160 million, or $0.61 per diluted share, from $359 million, or $1.38, a year earlier. The company lowered its full-year 2025 revenue guidance to $6.200 billion to $6.250 billion from $6.275 billion to $6.375 billion, a reduction in its outlook that matters to shareholders. Non-GAAP adjusted diluted EPS rose to $1.01 from $0.87.
Q3 2025 revenue was $1.602 billion, up 1% as reported and down 1% ex-FX; Women's Health fell 3% and Biosimilars rose 19%.
Reported gross margin was 53.5% versus 58.3% a year earlier; one-time manufacturing network optimization costs were the most significant driver.
Full-year 2025 revenue guidance was lowered to $6.200 billion to $6.250 billion; Adjusted EBITDA margin guidance was lowered to about 31.0% from 31.0% to 32.0%.
The board declared a quarterly dividend of $0.02 per share, payable December 11, 2025; Joe Morrissey is interim CEO.
Tyson Foods reported fourth-quarter fiscal 2025 sales of $13,860 million, up 2.2%, and adjusted EPS of $1.15, up 25%, while GAAP EPS fell to $0.13 from $1.00 a year earlier. The company also gave a fiscal 2026 outlook for total adjusted operating income of $2.1 billion to $2.3 billion and raised its quarterly dividend, so shareholders face a mix of higher adjusted results, a sharp GAAP profit decline and a guided adjusted operating income range that sits below fiscal 2025's $2,287 million.
Q4 sales of $13,860 million, up 2.2%; GAAP operating income of $158 million, down 70%
Q4 sales were reduced by $355 million in legal contingency accruals; GAAP EPS of $0.13 versus adjusted EPS of $1.15
Fiscal 2026 outlook: total adjusted operating income of $2.1 billion to $2.3 billion and sales up 2% to 4%, compared with fiscal 2025 adjusted operating income of $2,287 million
Quarterly dividend increased to $0.51 per Class A share, effective November 7, 2025
TDS reported third-quarter 2025 operating revenues from continuing operations of $308.5 million, down from $327.5 million a year earlier, while diluted earnings per share from continuing operations rose to $0.33 from a loss of $0.88. The company also authorized a new $500 million share repurchase program and named Anthony Carlson president and CEO of Array effective November 16, 2025.
Q3 2025 operating revenues from continuing operations: $308.5 million, versus $327.5 million in Q3 2024
Diluted EPS from continuing operations: $0.33, versus $(0.88) a year earlier
Net loss attributable to TDS common shareholders: $(99.1) million for the quarter, per the filing's income statement, including $(139.3) million from discontinued operations
New $500 million share repurchase program, with no expiration; TDS repurchased 1,077,564 shares for $40.7 million in Q3
DoubleVerify reported third-quarter 2025 revenue of $188.6 million, up 11% from a year earlier, with adjusted EBITDA of $65.9 million at a 35% margin. Net income fell to $10.2 million from $18.2 million, and diluted EPS was $0.06 versus $0.10. The company raised its full-year 2025 adjusted EBITDA margin guidance to approximately 33% from 32% and expects full-year revenue growth of approximately 14%.
Q3 2025 revenue of $188.6 million, up 11%; activation revenue $106.7 million, up 10%
Net income of $10.2 million versus $18.2 million in Q3 2024; diluted EPS $0.06 versus $0.10
Full-year 2025 adjusted EBITDA margin guidance raised to approximately 33% from 32%
Q4 2025 revenue guidance of $207 million to $211 million; adjusted EBITDA of $77 million to $81 million
Essent Group reported third-quarter 2025 net income of $164.2 million, or $1.67 per diluted share, down from $176.2 million, or $1.65 per diluted share, a year earlier. Total revenues were $311.8 million, compared with $316.6 million in the prior-year quarter, and the Board declared a $0.31 quarterly dividend and approved a new $500 million share repurchase authorization.
Net income was $164.2 million versus $176.2 million a year earlier, while diluted EPS rose to $1.67 from $1.65.
Total revenues were $311.8 million versus $316.6 million in Q3 2024.
Quarterly dividend of $0.31 per share is payable December 10, 2025, to holders of record on December 1, 2025.
Through October 31, the company had repurchased 8.7 million shares for $501 million; a $500 million authorization runs through year-end 2027.
Fluor reported third quarter 2025 revenue of $3.4 billion, down 18% from a year earlier, and a GAAP net loss attributable to Fluor of $697 million. The loss reflects a $653 million charge for the Santos ruling and a $401 million reduction tied to NuScale's share price, while adjusted EPS rose to $0.68 and the company raised its 2025 adjusted EPS and adjusted EBITDA guidance.
Q3 revenue was $3.4 billion, down 18% year over year, reflecting a $653 million reduction for the Santos ruling
Adjusted EPS was $0.68, up 33% year over year; GAAP EPS was ($4.30)
2025 adjusted EBITDA guidance raised to $510 million to $540 million from $475 million to $525 million
Q3 share repurchases were $70 million, with an additional $800 million targeted through February
Alliant Energy reported third-quarter 2025 GAAP EPS of $1.09, down from $1.15, and ongoing EPS of $1.12, also down from $1.15, while nine-month GAAP EPS rose to $2.59 from $2.10. The company narrowed its 2025 ongoing EPS guidance to $3.17-$3.23, issued 2026 ongoing EPS guidance of $3.36-$3.46, and raised its 2026 dividend target to $2.14 per share, which matters to shareholders because it sets the company's earnings and dividend outlook while raising its capital spending plan.
Q3 2025 GAAP EPS $1.09 vs $1.15; ongoing EPS $1.12 vs $1.15; Q3 revenue $1,210 million vs $1,081 million
Nine months 2025 GAAP EPS $2.59 vs $2.10 (up 23.3%); ongoing EPS $2.62 vs $2.33 (up 12.4%)
2026 ongoing EPS guidance $3.36-$3.46 (6.6% midpoint growth over 2025); 2026 dividend target $2.14 per share vs $2.03
Four-year capital expenditure forecast raised 17% to $13.4 billion; contracted data center demand of 3 GW
Alarm.com reported third-quarter 2025 results on November 6, 2025, with total revenue up 6.6% to $256.4 million and SaaS and license revenue up 10.1% to $175.4 million. GAAP net income fell slightly to $35.1 million, and diluted earnings per share were $0.65, down from $0.67 a year earlier. The company raised its full-year 2025 SaaS and license revenue guidance to $685.2 million to $685.4 million.
Q3 2025 total revenue rose 6.6% to $256.4 million, versus $240.5 million in Q3 2024.
GAAP net income was $35.1 million, compared with $36.5 million; diluted EPS was $0.65, compared with $0.67.
Non-GAAP adjusted EBITDA rose 18.4% to $59.2 million, compared with $50.0 million.
Full-year 2025 SaaS and license revenue guidance is now $685.2 million to $685.4 million, up $4.1 million from the prior midpoint.
Topgolf Callaway Brands reported third-quarter 2025 net revenue of $934.0 million, down 7.8% from $1,012.9 million a year earlier, mainly because of the sale of Jack Wolfskin. Excluding Jack Wolfskin, ongoing business revenue rose 3.2%, and the company raised its full-year 2025 revenue and Adjusted EBITDA guidance, though it still posted a GAAP net loss of $14.7 million for the quarter. Shareholders get a higher outlook for the year, but reported revenue and profit measures declined.
Q3 GAAP net loss of $14.7 million, or $0.08 per diluted share, versus a net loss of $3.6 million a year earlier
Full-year 2025 consolidated Adjusted EBITDA guidance raised to $490 million to $510 million from $430 million to $490 million
Full-year 2025 consolidated net revenue guidance raised to $3.90 billion to $3.94 billion from $3.80 billion to $3.92 billion
Company cited $12 million in incremental tariffs in its core business in Q3 and about $40 million of estimated tariff impact for 2025
Astrana Health reported third-quarter 2025 revenue of $956.0 million, up 100%, after closing its Prospect Health acquisition on July 1, 2025. Net income attributable to the company fell to $0.4 million from $16.1 million a year earlier, and it updated full-year 2025 guidance to revenue of $3.10 billion to $3.18 billion and adjusted EBITDA of $200 million to $210 million, citing delayed full-risk contract transitions.
Third-quarter total revenue $956.0 million, up 100% from $478.7 million; diluted EPS $0.01 versus $0.33.
Third-quarter adjusted EBITDA $68.5 million, up 52% from $45.2 million, at the higher end of guidance.
Full-year 2025 guidance: total revenue $3.10 billion to $3.18 billion; adjusted EBITDA $200 million to $210 million.
Third-quarter other expenses included $13.0 million for a legal matter with a provider tied to CFC Health Plan and $12.7 million in transaction and integration costs.
Northern Oil and Gas reported third quarter 2025 results on November 6, 2025, showing a GAAP net loss of $129.1 million, or $1.33 per share, after a non-cash $318.7 million impairment charge. That compares with net income of $298.4 million a year earlier. Production rose 8% from the year-earlier quarter, oil and gas sales fell to $482.2 million from $513.5 million, and 2025 production guidance was raised.
GAAP net loss of $129.1 million ($1.33 per share) versus net income of $298.4 million in Q3 2024, driven by a non-cash $318.7 million impairment
Oil and gas sales of $482.2 million, down from $513.5 million; Adjusted EBITDA of $387.1 million, down 6% year over year
2025 annual production guidance raised to 132,500 to 134,000 Boe per day; capital expenditure guidance tightened to $950 million to $1,025 million
Revolving credit facility amended November 5, 2025, extending maturity to November 2030; $0.45 per share dividend declared in November 2025
Solventum reported third-quarter 2025 sales of $2.1 billion, up 0.7% (2.7% organic), while adjusted diluted EPS fell 8.5% to $1.50. The company raised its full-year adjusted EPS range to $5.98 to $6.08 from $5.88 to $6.03 and launched a multiyear Transform for the Future program, which it expects to generate about $500 million in annual cost savings, though GAAP diluted EPS of $7.22 includes a $1.5 billion gain on the Purification and Filtration sale.
Q3 net sales $2,096 million, up 0.7%; organic sales up 2.7%
Adjusted diluted EPS $1.50 versus $1.64 a year earlier, down 8.5%; GAAP diluted EPS $7.22
Full-year adjusted EPS outlook raised to $5.98 to $6.08; free cash flow guidance revised to $150 million to $250 million
Transform for the Future expected to yield about $500 million in annual savings with about $500 million in cumulative pretax costs
Fox Factory reported third-quarter fiscal 2025 results on November 6, 2025, with net sales up 4.8% to $376.4 million but a net loss of $0.6 million, compared with net income of $4.8 million a year earlier. The company said its Specialty Sports Group underperformed as customers reduced inventories, and it updated its fourth-quarter and full-year 2025 outlook, now expecting fourth-quarter adjusted earnings per diluted share of $0.05 to $0.25. The company also reduced debt by $17 million and extended its credit agreement through October 2030.
Q3 net sales rose 4.8% to $376.4 million, but net loss was $0.6 million, or $0.02 per diluted share, versus net income of $4.8 million, or $0.11, a year earlier
Q3 adjusted earnings per diluted share were $0.23, down from $0.35; adjusted EBITDA was $44.4 million, up 5.7%
Fourth-quarter net sales now expected at $340 million to $370 million
Fiscal 2025 net sales expected at $1.445 billion to $1.475 billion and adjusted EPS at $0.92 to $1.12
ICU Medical reported third quarter 2025 revenue of $537.0 million, down from $589.1 million a year earlier, after disposing of its IV Solutions business on May 1, 2025. Its GAAP net loss narrowed to $(3.4) million, or $(0.14) per diluted share, from $(33.0) million, and it raised its full-year 2025 adjusted EBITDA and adjusted EPS guidance. Shareholders get higher profit measures alongside lower sales.
Q3 2025 revenue was $537.0 million versus $589.1 million in Q3 2024; Vital Care revenue fell to $78.0 million from $164.5 million.
Q3 2025 GAAP net loss was $(3.4) million, or $(0.14) per diluted share, compared with $(33.0) million, or $(1.35), a year earlier.
Q3 2025 adjusted diluted EPS was $2.03 versus $1.59; adjusted EBITDA was $105.9 million versus $94.8 million.
Fiscal 2025 adjusted EPS guidance was raised to $7.35–$7.65 from $6.85–$7.15, and adjusted EBITDA guidance to $395 million–$405 million from $380 million–$390 million.
StepStone reported results for the quarter ended September 30, 2025, with total revenues up 67% to $454.2 million and management and advisory fees up 17% to $215.5 million. A GAAP net loss of $575.5 million, or $4.66 per share, compared with net income of $53.1 million a year earlier, reflecting equity-based compensation of $884.5 million, while adjusted net income rose 25% to $66.7 million.
Total revenues were $454.2 million versus $271.7 million a year earlier; total performance fees were $238.7 million.
GAAP net loss was $575.5 million, or $4.66 per share, versus net income of $53.1 million, or $0.26 per share; equity-based compensation was $884.5 million versus $37.3 million.
Adjusted net income rose to $66.7 million, or $0.54 per share, from $53.6 million, or $0.45 per share; fee-related earnings were $78.6 million, up 9%.
The board declared a quarterly dividend of $0.28 per share, up from $0.24, payable December 15, 2025, to holders of record on November 28, 2025.
Gen Digital reported record second-quarter fiscal 2026 revenue of $1.22 billion, up 25%, and raised its full-year fiscal 2026 non-GAAP revenue and EPS guidance. GAAP diluted EPS fell 17% to $0.21, and GAAP net income declined, partly due to a $69 million change in fair value and impairment of non-marketable equity investments.
Q2 revenue of $1,220 million, up 25%; non-GAAP diluted EPS of $0.62, up 15%
GAAP diluted EPS of $0.21, down from $0.26 a year earlier; GAAP net income of $134 million vs. $161 million
FY26 revenue guidance raised to $4.92 billion-$4.97 billion from $4.8 billion-$4.9 billion
Quarterly dividend of $0.125 per share payable December 10, 2025, to holders of record on November 17, 2025
DiamondRock Hospitality reported third quarter 2025 results, with net income attributable to common stockholders down 16.3% year over year to $20.1 million while Adjusted EBITDA rose 2.7% to $79.1 million. The company raised the midpoint of its full-year 2025 Adjusted EBITDA and Adjusted FFO guidance, and it repaid its remaining secured mortgage debt, leaving its portfolio unencumbered.
Net income attributable to common stockholders was $20.1 million, or $0.10 per diluted share, down from $24.0 million in the third quarter of 2024.
Adjusted EBITDA was $79.1 million, up 2.7%; Adjusted FFO per diluted share was $0.29, up 7.4%.
2025 Adjusted EBITDA guidance is $287 million to $295 million, versus $275 million to $295 million previously; Adjusted FFO per share guidance is $1.02 to $1.06, versus $0.96 to $1.06.
Year to date through November 6, 2025, the company repurchased 4.8 million shares for about $37.1 million, with $137.0 million remaining under its $200.0 million program.
Peloton reported fiscal first-quarter 2026 results for the quarter ended September 30, 2025. Revenue fell 6% year-over-year to $551 million, while net income rose to $14 million and adjusted EBITDA reached $118 million. The company raised its full-year fiscal 2026 adjusted EBITDA guidance to $425 million to $475 million, but its full-year revenue outlook of $2.4 billion to $2.5 billion was unchanged and implies a 2% decline at the midpoint.
Total revenue was $551 million, down $35 million or 6% year-over-year, and $6 million above the high end of guidance.
Net income was $14 million, up $15 million year-over-year; adjusted EBITDA was $118 million, up 2%.
Ending paid connected fitness subscriptions were 2.732 million, down 6% year-over-year.
Full-year fiscal 2026 adjusted EBITDA outlook was raised by $25 million to $425 million to $475 million; revenue outlook was unchanged.
Viatris reported third-quarter 2025 total revenues of $3.8 billion, flat on a reported basis, and a U.S. GAAP net loss of $128 million, compared with net earnings of $95 million a year earlier. The company attributed the loss mainly to a reduction in the fair value of its Biocon Biologics preferred shares and higher income tax expense, and it raised and narrowed its 2025 guidance ranges for total revenues, adjusted EBITDA and adjusted EPS.
Q3 2025 total revenues were $3.8 billion, flat reported and down 1% on a divestiture-adjusted operational basis; the estimated Indore Impact was about $100 million in the quarter.
Q3 2025 U.S. GAAP net loss was $(128) million, or $(0.11) per share, versus net earnings of $95 million, or $0.08 per share, in Q3 2024; adjusted EPS was $0.67, down 11% reported.
2025 guidance now shows total revenues of $13.9 billion to $14.3 billion (previously $13.5 billion to $14.0 billion) and adjusted EPS of $2.25 to $2.35 (previously $2.16 to $2.30).
Year-to-date, Viatris returned more than $920 million to shareholders, including $500 million in share repurchases.
Air Products reported a fiscal 2025 GAAP loss of $1.74 per diluted share and an operating loss of $877 million, compared with GAAP earnings of $17.24 per share in fiscal 2024. The results include about $3.7 billion in pre-tax charges for business and asset actions, while adjusted EPS of $12.03 beat the guidance midpoint but fell 3% from the prior year. The company also guided fiscal 2026 adjusted EPS to $12.85 to $13.15 and expects capital expenditures of about $4 billion.
Fiscal 2025 sales were $12.0 billion, down 1% from the prior year, with GAAP diluted loss per share of $1.74 versus $17.24 in fiscal 2024
Pre-tax business and asset action charges were about $3.7 billion ($3.0 billion after tax, or $13.68 per share)
Adjusted EPS of $12.03 exceeded the guidance midpoint and decreased 3% from the prior year
Fiscal 2026 adjusted EPS guidance is $12.85 to $13.15; first quarter guidance is $2.95 to $3.10; capital expenditures expected at about $4 billion
N-able reported third-quarter 2025 revenue of $131.7 million, up 13.1% year over year, and total ARR of $528.1 million, up 14.2%. It raised its full-year 2025 ARR outlook to $530 million to $531 million, but GAAP net income fell to $1.4 million, or $0.01 per diluted share, from $10.8 million a year earlier.
Q3 revenue $131.7 million, up 13.1% year over year (11.6% constant currency)
GAAP net income $1.4 million, or $0.01 per diluted share, versus $10.8 million in Q3 2024; non-GAAP net income $25.4 million, or $0.13 per diluted share
Adjusted EBITDA $41.4 million, a 31.4% margin
Q4 2025 revenue outlook $126.5 million to $127.5 million; full-year 2025 adjusted EBITDA outlook $148.2 million to $149.2 million
Rockwell Automation reported fiscal fourth-quarter 2025 sales of $2,316 million, up 14%, but diluted EPS fell to $1.23 from $2.09 after a $110 million Sensia impairment and $136 million in legacy asbestos charges. Adjusted EPS rose 32% to $3.34 under a revised definition, and the company introduced fiscal 2026 diluted EPS guidance of $10.40 to $11.40 while agreeing with SLB to dissolve the Sensia joint venture.
Fiscal Q4 2025 sales were $2,316 million, up 14% from $2,035 million; diluted EPS was $1.23 versus $2.09, and Adjusted EPS was $3.34 versus $2.53.
Full fiscal 2025 sales were $8,342 million, up 1%; diluted EPS was $7.67 versus $8.28 and Adjusted EPS was $10.53 versus $9.85.
Fiscal 2026 guidance calls for reported sales growth of 3% to 7%, diluted EPS of $10.40 to $11.40, and Adjusted EPS of $11.20 to $12.20.
Sensia dissolution is expected to close in the first half of fiscal 2026, and Q4 included a $110 million non-cash impairment charge tied to it.
Middleby reported third-quarter 2025 net sales of $982 million, up 4.2% from a year earlier but flat on an organic basis, and a GAAP net loss of $513 million, or $(10.15) per diluted share. The loss reflects a $709 million non-cash impairment tied to a strategic review of the Residential Kitchen business, which the company says it is evaluating alternatives for. Adjusted EPS was $2.37 versus $2.33 a year earlier, and the company said profitability was at the top end of its outlook, though shareholders face a large write-down and an uncertain outcome for that unit.
Net sales of $982 million, up 4.2%; organic net sales decreased 0.1%
Non-cash impairment charge of $709 million tied to the Residential Kitchen strategic review; diluted EPS of $(10.15)
Adjusted EPS of $2.37 versus $2.33 a year earlier; operating cash flow of $176 million
Q4 2025 outlook: total revenue of $990-1,020 million and adjusted EPS of $2.19-2.34
Teleflex reported third-quarter 2025 GAAP revenue of $913.0 million, up 19.4%, and a GAAP diluted loss of $(9.24) per share, compared with earnings of $2.36 a year earlier. The loss reflects a $403.9 million non-cash goodwill impairment on its Interventional Urology North America unit, and the company lowered its full-year 2025 GAAP EPS and adjusted constant currency revenue growth outlooks, which matters because the charges and cut weigh directly on reported results.
Q3 GAAP revenue $913.0 million, up 19.4%; adjusted revenue $892.9 million, up 16.8%
Q3 adjusted diluted EPS $3.67 versus $3.49 a year earlier; GAAP diluted EPS $(9.24) versus $2.36
2025 GAAP diluted EPS outlook lowered to $(4.42) to $(4.22) from $6.73 to $7.13; adjusted EPS narrowed to $14.00 to $14.20
Adjusted constant currency revenue growth outlook lowered to 6.90% to 7.40% from 7.70% to 8.70%
AAON reported third-quarter 2025 net sales up 17.4% to $384.2 million and a record backlog of $1.32 billion, but gross margin fell to 27.8% from 34.9% a year earlier and diluted EPS dropped to $0.37. The company raised its 2025 sales growth outlook to mid-teens from low-teens, while narrowing its gross margin range to 28.0%-28.5% from 28.0%-29.0%.
Net sales rose 17.4% year over year to $384.2 million; BASX-branded sales rose 95.8% to $124.8 million.
Diluted EPS was $0.37, down 41.3% year over year; gross margin was 27.8%, versus 34.9% in the prior-year quarter.
Backlog reached a record $1.32 billion, up 103.8% year over year and 18.1% from June 30, 2025.
2025 outlook: YoY sales growth raised to mid-teens from low-teens; gross margin guidance 28.0%-28.5% versus prior 28.0%-29.0%.
Vistra reported third quarter 2025 GAAP net income of $652 million, down $1.185 billion from a year earlier, mainly due to lower unrealized mark-to-market gains, while Ongoing Operations Adjusted EBITDA rose 10% to $1.581 billion. The company narrowed its 2025 Adjusted EBITDA guidance to $5.7 billion to $5.9 billion and initiated 2026 Adjusted EBITDA guidance of $6.8 billion to $7.6 billion, and its board added $1.0 billion to its share repurchase authorization.
Q3 2025 operating revenues were $4,971 million, down from $6,288 million in Q3 2024.
Q3 2025 Ongoing Operations Adjusted EBITDA was $1,581 million, up $143 million from $1,438 million, driven by higher realized energy and capacity prices and nuclear PTC revenue.
2025 Adjusted EBITDA guidance narrowed to $5.7 billion to $5.9 billion; 2026 guidance initiated at $6.8 billion to $7.6 billion.
Board authorized an additional $1.0 billion of share repurchases, expected to be used by year-end 2027.
Granite reported third-quarter 2025 results, with revenue up 12% to $1.43 billion and net income attributable to Granite up 30% to $103 million. The company narrowed its full-year 2025 revenue guidance by lowering the top of the range to $4.45 billion, while raising its adjusted EBITDA margin range, so shareholders get strong quarterly growth alongside a lower revenue ceiling.
Q3 revenue rose 12% year-over-year to $1.43 billion; diluted EPS was $1.98 versus $1.57 a year earlier.
Adjusted diluted EPS was $2.70, up 32% from $2.05 in the prior-year quarter.
2025 revenue guidance narrowed to $4.35 billion to $4.45 billion from $4.35 billion to $4.55 billion; adjusted EBITDA margin guidance raised to 11.50% to 12.50% from 11.25% to 12.25%.
Committed and awarded projects reached a record $6.3 billion, up $273 million sequentially.
Enovis reported third-quarter 2025 net sales of $549 million, up 9% on a reported basis and 7% organically, and raised its full-year adjusted EBITDA and adjusted EPS guidance. The GAAP net loss of $571 million, or $9.99 per share, reflects a non-cash goodwill impairment charge of $548 million, which the company says does not affect future operations.
Q3 adjusted EBITDA was $95 million (17.3% of sales), compared with $90 million (17.9%) a year earlier; adjusted EPS was $0.75 versus $0.73.
Full-year 2025 adjusted EBITDA guidance rose to $395-405 million from $392-402 million; adjusted EPS guidance rose to $3.10-3.25 from $3.05-3.20.
Full-year revenue guidance is $2.24-2.27 billion, versus prior $2.245-2.275 billion, including a $15 million reduction tied to the Dr. Comfort divestiture completed in October 2025.
In October 2025, Enovis divested its Diabetic Footcare business unit from Prevention & Recovery for total proceeds of up to $60 million.
DuPont reported third quarter 2025 net sales of $3.1 billion, up 7%, and raised its full-year 2025 operating EBITDA guidance for the new DuPont to about $1.6 billion, after the Electronics separation. GAAP EPS from continuing operations fell 34% to $0.70 on higher separation costs, while adjusted EPS was flat at $1.09. The board also approved a $2 billion share repurchase authorization, including a planned $500 million accelerated share repurchase, and a $0.20 quarterly dividend.
Q3 2025 net sales of $3,072 million, up 7% from $2,862 million; organic sales up 6%
GAAP EPS from continuing operations of $0.70, down from $1.06; adjusted EPS flat at $1.09
FY 2025 operating EBITDA guidance raised to about $1.6 billion from about $1,575 million; adjusted EPS guidance about $1.66
$2 billion share repurchase authorization, $500 million accelerated share repurchase, and $0.20 quarterly dividend payable December 15, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.